Resound Vivia 9 60S microRIE vs Signia Pure C&G IX

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates notable strengths in speech clarity during quiet listening situations, scoring 4.0/5—a strong result that sits 0.57 points above the category average. Own-voice comfort is another highlight, measuring 0.65 points above average at 3.4/5, which may appeal to users sensitive to how their own speech sounds while wearing hearing aids. However, the Vivia 9 shows limitations in challenging acoustic environments. Speech-in-noise performance scores just 1.3/5, falling 0.25 points below the category average—a consideration for those frequently in noisy restaurants or social gatherings. Feedback handling, while strong in absolute terms at 4.2/5, measures 0.51 points below what other prescription devices achieve on average. Music streaming performance is mixed at 2.6/5, essentially matching the category norm. The Vivia 9 includes modern conveniences: rechargeable batteries, direct streaming to both iPhone and Android devices, and hands-free calling capability. Buyers seeking top-tier performance in this price range may want to compare alternatives like the Oticon Intent or Phonak Sphere Infinio, which scored notably higher in our testing. The Vivia 9 is best suited for users who prioritize clear speech in quieter settings and natural own-voice perception over challenging noise performance.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earns an A grade with a SoundScore of 4.0/5, placing it in the top 50% of prescription hearing aids tested. Speech performance is a notable strength. Speech in quiet scores a strong 4.1/5, which is +0.67 points above the category average of 3.43/5. Speech in noise scores 2.3/5—above the category average of 1.55/5 by +0.75 points, though still mixed in absolute terms. This pattern is common in the prescription category, where challenging noise environments remain difficult for most devices. Feedback handling is excellent at 5.0/5, scoring +0.29 points above the already-high category average. Own-voice comfort comes in at a solid 3.2/5, which is +0.45 points above average. Music streaming scores 3.0/5, a solid result that sits +0.36 points above category norms. Professional fitting makes a meaningful difference with this device. The normalized Initial Score of 3.8/5 improves to 4.5/5 after tuning—a +0.7 point gain that reflects substantial speech clarity improvements when properly configured. The Pure C&G IX includes rechargeable batteries and streaming compatibility with both iPhone and Android devices, plus hands-free calling capability. It's well-suited for users who prioritize speech clarity and can work with a hearing care professional to optimize their fitting.